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1. INTRODUCTION
• Description of the problem of burns and burn site infections
• Alternatives to antibiotics: Bacteriophages
• Available technologies and implementation of the 
emulsification technique as an effective storage/delivery 
medium 
• Burns and burn infections1
Burns are experienced by thousands of people every year in the 
UK with high associated costs.
• Children under two years old are 
the most vulnerable to burn 
wound infections.
• Minor and moderate burns 
caused by scalds or spillages
are the most common.
• The majority of cases are 
domestic injuries (79%).
• Complications caused by Toxic 
Shock Syndrome.
1 “UK Burn Injury Data (1986-2007 inc.),” 2008. [Online]. Available: http://www.ibidb.org/. [Accessed: 02-Feb-2012].
2 European Centre for Disease Prevention and Control, “Antimicrobial resistance surveillance in Europe 2010. Annual
Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net).,” 2011.
Methicillin Resistant S. aureus in Europe (2010)
• Antibiotic Resistance – Evolution in Europe2
50% of infection 
cases showed 
antibiotic 
resistance
3 European Centre for Disease Prevention and Control, “Antimicrobial resistance surveillance in Europe 2012. Annual
Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net).,” 2013.
Methicillin Resistant S. aureus in Europe (2012)
50% of infection 
cases showed 
antibiotic 
resistance
• Antibiotic Resistance – Evolution in Europe3
•Increasing 
bacterial 
antibiotic 
resistance in 
Europe due 
to misuse or 
abuse
•Necessity of 
alternatives  
• Alternatives to antibiotics
• Improved antibiotics – difficult to make
Example: Only Linezolid has been approved for the treatment of acute
skin infections since 2000, although Tedizolid is currently being
developed.
• Molecular Biology techniques to make bacteria more susceptible to
antibiotics
• Activated antibacterial agents
• Bacteriophages
4P. W. Taylor, P. D. Stapleton, and J. Paul Luzio, “New ways to treat bacterial infections.,” Drug discovery today, vol. 
7, no. 21, pp. 1086-91, Nov. 2002.
Alternative therapies are emerging as a consequence of the 
widespread antibiotic resistance4:
2• Phage therapy as an alternative to antibiotics
• Bacteriophages have been used against skin and wound infections, 
with reported success rates of up to 90% against S. aureus 7.
• The advantages of bacteriophage therapy include their abundance 
and ecological ‘friendliness’; they can be used as a ‘phage-cocktail’, 
they multiply exponentially, and they do not generate unwanted side-
effects 8.
• There are challenges to implementing phage therapy in vivo, which 
may be partially addressed by modelling of population dynamics.
7 Ahmad SI. 2002. Treatment of post-burns bacterial infections by bacteriophages, specifically ubiquitous 
Pseudomonas spp. notoriously resistant to antibiotics. Medical Hypotheses 58:327–31. 
8 Hanlon GW. 2007. Bacteriophages: an appraisal of their role in the treatment of bacterial infections. International 
Journal of Antimicrobial Agents 30:118–28. 
• Available Emulsification Technologies
PIT 
Emulsification
Homogenisation
2. PROJECT AIMS
• Delivery of phage or ‘phage-cocktail’ to the point of infection without 
losing efficacy, either during delivery, or prior storage. 
• Use of oil-in-water nano-emulsions as a stabilising / delivery 
vehicle, due to their capacity to prevent virus precipitation, and to 
enhance transdermal penetration.
• Understanding the mechanisms of interaction in a mixture 
containing emulsion droplets, bacteriophage, and bacteria, and the 
relative effects of emulsion and phage on bacterial growth.
3. RESULTS
• Emulsification techniques
• Influence of oil-in-water Nanoemulsions on bacterial growth
• Influence of oil-in-water Nanoemulsions on bacteriophage 
lytic activity
• Product shelf-life
• Bacterial Biofilms
• Emulsification Techniques: PIT vs. Homogenisation
For the same formulation 80% SM Buffer (aq. phase), 15 % BrijO10 (surfactant), 
5% Soybean oil (organic phase)
PIT Emulsification Homogenisation after 45 min
3• Emulsification Techniques: PIT vs. Homogenisation
For the same formulation 80% SM Buffer (aq. phase), 15 % BrijO10 (surfactant), 
5% Soybean oil (organic phase)
PIT 
Emulsification
Homogenisation
after 45 min
• Influence of Emulsion on Bacterial Growth 
• Bacterial growth in more concentrated emulsion (1:1 dilution) appeared 
slower, showing a lag period.
• RSM Analysis showed that both growth rate and carrying capacity were 
influenced by the concentration of emulsion droplets.
Two different strains
P. P. Esteban et al. Biotechnol.
Prog., 30:932–944, 2014
Streptomycin in water
• Influence of Emulsion on Bacterial Growth: Testing 
Streptomycin penetration
• Bacterial growth may be influenced by attachment of emulsion droplets to the
outer cell membrane, depriving bacteria of nutrients.
• If so, penetration of antibiotics should also be affected.
Streptomycin in the 
presence of emulsion
P. P. Esteban et al. (In
preparation)
• Influence of Emulsion on Bacterial Growth: Different 
Antibiotic Mechanisms - Streptomycin
• Streptomycin needs to go through and reach the ribosomes of the cell.
• It binds irreversibly to the 30S ribosomal subunit.
• Codon misreading and protein inhibition.
• Influence of Emulsion on Bacterial Growth: Different 
Antibiotic Mechanisms - Vancomycin
• Vancomycin sits on the cell wall surface.
• It binds to the two D-ala residues.
• It inhibits cell wall synthesis.
• Influence of Emulsion on Bacterial Growth: 
Mechanism and/or Cell Wall Structure?
S. aureus P. aeruginosa
4• Influence of Emulsion on Bacteriophage K Lytic 
Activity
• Bacterial concentration was dramatically reduced after the first 5 hours of 
treatment with bacteriophage-emulsion formulation, when compared with 
bacterial growth in emulsion. Re-growth is also avoided.
Two different strains
P. P. Esteban et al. Biotechnol.
Prog., 30:932–944, 2014
• Influence of Emulsion on Bacteriophage K Lytic 
Activity: Possible mechanism? – Zeta Potential
Bacteriophage K only
Bacteriophage K + 
Nano-Emulsion
-15 mV
-1.3 mVNano-Emulsions 
reduce Bacteriophage 
K Zeta Potential –
Might eliminate 
electrostatic repulsion 
bacteria-bacteriophage
• Shelf-life of Bacteriophage K-Emulsion 
Preparations
Relative killing effect =OD20h (control)OD20h (within phage preparation)
OD20h (control)
• Relative killing effect = 1 
Total killing of bacteria
• Relative killing effect = 0 No 
killing effect
Bacteriophage-emulsion 
formulations, both at room 
(~20oC) and cold (4oC) 
temperature show enhanced 
antibacterial activity.
P. P. Esteban et al. Biotechnol.
Prog., 30:932–944, 2014
• Growth of Bacterial Biofilms – Crystal Violet Assay
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P. P. Esteban et al. (In
preparation)
• Eradication of Bacterial Biofilms – Crystal Violet 
Assay
Eradication with Phage 
cocktail in Buffer
Eradication with Phage 
cocktail in Emulsion
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preparation)
• Bacterial Biofilms – Modified Robbins Device
54. MODELLING STRATEGIES
• Modelling of bacterial growth – Test of existing models.
• Influence of the ratio emulsion droplets : bacterial cells on 
growth parameters.
• Proposal of a modified logistic growth model in the 
presence of emulsion droplets.
• Infectivity models: general principles and difficulties.
• Modelling bacterial growth
Model Formulation Parameters
Logistic
a=Growth rate (time-1)
K=Carrying capacity 
(concentration)
Gompertz
a=Growth rate (time-1)
K=Carrying capacity 
(concentration)
Richards
a=Growth rate (time-1)
K=Carrying capacity 
(concentration)
Parameter
Hyperbolastic H1
If       0 - equivalent to the Logistic 
model.
a=Intrinsic growth rate (time-1
concentration-1)
K=Carrying capacity 
(concentration)
Parameter
dS(t)
dt
 aS(t) 1 S(t)
K




dS(t)
dt
 aS(t)log K
S(t)




dS(t)
dt
 aS(t) 1 S(t)
K





dS(t)
dt
 1
K
S(t) K  S(t)  Ka 1 t2




 
  
• Modelling bacterial growth - METHOD
• In-built parameter estimation model of Matlab (lsqnonlin) not 
powerful enough for stiff systems of DEs. 
• Self-made parameter estimation algorithm using Matlab.
• Multistart run for 100 random initial guesses for all growth 
models.
• Determination of parameters, % of hits using different initial 
guesses, and value of total residual after fitting.
• Preferred model – Simplest model.
• Modelling bacterial growth - RESULTS
• Logistic model yields smaller residual and all models’ 
parameters lead towards logistic model
% 
of 
hits
Value 
of a
• Influence of the ratio emulsion droplets : bacterial 
cells on growth parameters.
• First moments of 
growth curve can 
be approximated to 
an exponential –
Fitting growth rate
• Use  different initial 
dilution factors of 
emulsion (vary 
amount of droplets 
per bacteria)
• Proposal of a modified logistic growth model in the 
presence of emulsion droplets.
• Growth rate is dependent on the droplet : bacteria ratio.
• What about carrying capacity?
dS(t)
dt
 aS(t) 1 S(t)
K




dS(t)
dt
 a0eDFS(t) 1 S(t)K




New growth model
6• Infectivity models
• Steps from a microscopic point of view:
1. Diffusion or transport from the bulk of the solution to bacterial 
surface.
2. Recognition and adsorption due to specific receptors on bacterial 
outer membrane.
3. Injection of bacteriophage genetic material.
4. Bacteriophage self-replication.
• General mass-action law.
• Alternatives to antibiotics: Bacteriophages’ mode of 
action
• Infectivity models
• General system of ODEs:
dS
dt
 Rate of appearance of bacteria by growth  Rate of disappearance of bacteria by infection 
dI
dt
 Rate of appearance of bacteria  Bacterial Infection Rate 
 Bacterial  Inactivation Rate  Bacterial Lysis Rate 
dP
dt
 Phage Inflow Rate  Phage Inactivation Rate  Phage Adsorption Rate 
 Phage Release of Progenie Rate 





• Infectivity models - Example
dS(t)
dt
 aS(t) 1 S(t)
C



 bS(t)P(t)
dI(t)
dt
 aI(t) 1 I(t)
C



 bS(t)P(t) kI(t)
dP(t)
dt
 kLI(t)bS(t)P(t)mP(t)
• Infectivity models - Difficulties
• System of ODEs very non-linear.
• Parameter estimation is not trivial.
• Outcome highly dependent on initial guesses of parameters.
• Having a working and reliable parameter estimation method 
would help elucidating the mechanisms.
• Possible improvement: experimental determination of some 
parameters and use them as initial guesses/fixed parameters.
5. CONCLUSIONS
• We present a novel approach for the efficient storage and delivery 
of Bacteriophage K for the treatment of Staphylococcus aureus
infections. 
• More concentrated oil-in-water nano-emulsions had a bigger effect 
on bacterial growth.
• The nano-emulsion-bacteriophage preparations show enhanced 
and stable antimicrobial activity, with reduced fluctuations of 
infectivity over time, when compared to a simple phage suspension.
• This work demonstrates the potential for a responsive wound 
dressing preparation.
76. ONGOING WORK
• Investigation of the influence of outer cell wall properties on 
emulsion formulations performance in terms of growth and phage 
infectivity – Pseudomonas aureuginosa (Gram negative bacteria)
• Experimental determination of some of the infectivity parameters in 
order to achieve better fitting for the modelling strategies.
• Investigation of more realistic wound environments, where the 
presence of biofilms is determinant and critical – Use of our 
formulations in S. aureus and P. aureuginosa biofilms.
7. FUTURE WORK
• We are exploring the biological mechanisms within the system 
and evaluating more favourable formulations in terms of 
biocompatibility and cost.
• We are evaluating more comprehensive approaches to modelling
the bacteriophage / emulsion / bacterial interactions.
• We are moving towards a more realistic wound environment. 
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